Merit Financial Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04M | Buy |
207,849
+48,978
| +31% | +$1.19M | 0.06% | 276 |
|
|
2025
Q1 | $4.03M | Buy |
158,871
+30,904
| +24% | +$783K | 0.06% | 259 |
|
|
2024
Q4 | $3.39M | Buy |
127,967
+48,397
| +61% | +$1.28M | 0.06% | 251 |
|
|
2024
Q3 | $2.3M | Sell |
79,570
-7,635
| -9% | -$221K | 0.05% | 254 |
|
|
2024
Q2 | $2.44M | Sell |
87,205
-13,264
| -13% | -$371K | 0.05% | 240 |
|
|
2024
Q1 | $2.79M | Buy |
100,469
+24,431
| +32% | +$679K | 0.07% | 223 |
|
|
2023
Q4 | $2.19M | Sell |
76,038
-22,970
| -23% | -$661K | 0.07% | 190 |
|
|
2023
Q3 | $3.28M | Sell |
99,008
-1,469
| -1% | -$48.7K | 0.11% | 146 |
|
|
2023
Q2 | $3.69M | Buy |
100,477
+31,918
| +47% | +$1.17M | 0.12% | 129 |
|
|
2023
Q1 | $2.8M | Sell |
68,559
-4,378
| -6% | -$179K | 0.1% | 151 |
|
|
2022
Q4 | $3.74M | Buy |
72,937
+4,416
| +6% | +$226K | 0.14% | 116 |
|
|
2022
Q3 | $3M | Sell |
68,521
-5,667
| -8% | -$248K | 0.13% | 112 |
|
|
2022
Q2 | $3.89M | Buy |
74,188
+37,414
| +102% | +$1.96M | 0.12% | 104 |
|
|
2022
Q1 | $1.9M | Buy |
36,774
+8,444
| +30% | +$437K | 0.11% | 106 |
|
|
2021
Q4 | $1.67M | Sell |
28,330
-291
| -1% | -$17.2K | 0.16% | 67 |
|
|
2021
Q3 | $1.23M | Buy |
28,621
+2,323
| +9% | +$99.9K | 0.13% | 79 |
|
|
2021
Q2 | $1.03M | Buy |
26,298
+55
| +0.2% | +$2.15K | 0.1% | 96 |
|
|
2021
Q1 | $951K | Buy |
26,243
+2,734
| +12% | +$99.1K | 0.1% | 96 |
|
|
2020
Q4 | $865K | Sell |
23,509
-1,297
| -5% | -$47.7K | 0.08% | 94 |
|
|
2020
Q3 | $864K | Buy |
24,806
+8,289
| +50% | +$289K | 0.08% | 98 |
|
|
2020
Q2 | $512K | Buy |
16,517
+2,862
| +21% | +$88.7K | 0.05% | 127 |
|
|
2020
Q1 | $423K | Buy |
13,655
+651
| +5% | +$20.2K | 0.05% | 138 |
|
|
2019
Q4 | $483K | Buy |
+13,004
| New | +$483K | 0.04% | 146 |
|